Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David MacKintosh

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Annals of Palliative Medicine|September 5, 2017
Olanzapine induced delirium-a "probable" adverse drug reactionDavid MacKintosh
Journal of Medical Ethics|January 22, 2015
Demise of the LCP: villain or scapegoat?David MacKintosh
Journal of Palliative Medicine|September 24, 2015
Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case SeriesDavid MacKintosh
Cell Biology International|April 26, 2003
Mitogenic activity of insulin in the culture of a trypanosome: duration and dose responseDavid Mackintosh, Kim Coleman, Angela J Davies
Internal Medicine Journal|December 17, 2019
Short- and long-term outcomes of neutropenic cancer patients in intensive care according to requirement for invasive ventilationDavid Mackintosh, Mandy Way, Michael C Reade, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2019
Immune checkpoint inhibitor use in antisynthetase syndromeDavid Mackintosh, Mohammed F Islam, Jennifer Ng, et al.
The Journal of Experimental Biology|December 5, 2006
Beta-1, 3-glucan modulates PKC signalling in Lymnaea stagnalis defence cells: a role for PKC in H2O2 production and downstream ERK activationAudrey H Lacchini, Angela J Davies, David Mackintosh, et al.
BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
International Journal of Oncology|January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibitionNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Annals of Palliative Medicine|September 5, 2017
Olanzapine induced delirium-a "probable" adverse drug reactionDavid MacKintosh
Journal of Medical Ethics|January 22, 2015
Demise of the LCP: villain or scapegoat?David MacKintosh
Journal of Palliative Medicine|September 24, 2015
Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case SeriesDavid MacKintosh
Cell Biology International|April 26, 2003
Mitogenic activity of insulin in the culture of a trypanosome: duration and dose responseDavid Mackintosh, Kim Coleman, Angela J Davies
Internal Medicine Journal|December 17, 2019
Short- and long-term outcomes of neutropenic cancer patients in intensive care according to requirement for invasive ventilationDavid Mackintosh, Mandy Way, Michael C Reade, et al.
Asia-Pacific Journal of Clinical Oncology|March 1, 2019
Immune checkpoint inhibitor use in antisynthetase syndromeDavid Mackintosh, Mohammed F Islam, Jennifer Ng, et al.
The Journal of Experimental Biology|December 5, 2006
Beta-1, 3-glucan modulates PKC signalling in Lymnaea stagnalis defence cells: a role for PKC in H2O2 production and downstream ERK activationAudrey H Lacchini, Angela J Davies, David Mackintosh, et al.
BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
International Journal of Oncology|January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibitionNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Pageof 2